Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aromatic L-amino-acid decarboxylase (AADC), also known as DOPA decarboxylase (DDC), is a pyridoxal phosphate-dependent enzyme that catalyzes the decarboxylation of aromatic L-amino acids, including L-DOPA to dopamine and 5-HTP to serotonin. It plays a crucial role in the synthesis of monoamine neurotransmitters and is implicated in AADC deficiency, a rare neurometabolic disorder.
Catalyzes the decarboxylation of aromatic L-amino acids, converting L-DOPA to dopamine and 5-HTP to serotonin. Also involved in synthesis of trace amines.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aromatic L-amino-acid Decarboxylase (AADC).